Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration

Experimental Cell Research

Volumn 314, Issue 15, 2008, Pages 2762-2773

  Ravid, Dana ^a   Chuderland, Dana ^a   Landsman, Limor ^a   Lavie, Yaakov ^a   Reich, Reuven ^b   Liscovitch, Mordechai ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Akt; Cancer; Caveolin; Filamin; Migration

Indexed keywords

CAVEOLIN 1; DETERGENT; FILAMIN A; MESSENGER RNA; PROTEIN ANTIBODY; SERINE; SOMATOMEDIN C; WORTMANNIN;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; DRUG INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 50049106405     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.06.004     Document Type: Article

References (84)

1. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., and Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293 (2001) 2449-2452
2. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., Macaluso F., Russell R.G., Li M., Pestell R.G., Di Vizio D., Hou H.J., Knietz B., Lagaud G., Christ G.J., Edelmann W., and Lisanti M.P. Caveolin-1 null mice are viable, but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276 (2001) 38121-38138
3. Anderson R.G.W. The caveolae membrane system. Annu. Rev. Biochem. 67 (1998) 199-225
4. Liu P., Rudick M., and Anderson R.G. Multiple functions of caveolin-1. J. Biol. Chem. 277 (2002) 41295-41298
5. Parton R.G. Caveolae-from ultrastructure to molecular mechanisms. Nat. Rev. Mol. Cell Biol. 4 (2003) 162-167
6. Williams T.M., and Lisanti M.P. The caveolin proteins. Genome Biol. 5 (2004) 214.211-214.218
7. Li S., Couet J., and Lisanti M.P. Src tyrosine kinases, Ga subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 271 (1996) 29182-29190
8. Couet J., Li S., Okamoto T., Ikezu T., and Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272 (1997) 6525-6533
9. Razani B., Woodman S.E., and Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 54 (2002) 431-467
10. Liu P., Li W.P., Machleidt T., and Anderson R.G. Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells. Nat. Cell Biol. 1 (1999) 369-375
11. Li W.P., Liu P., Pilcher B.K., and Anderson R.G. Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J. Cell Sci. 114 (2001) 1397-1408
12. Koleske A.J., Baltimore D., and Lisanti M.P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1381-1385
13. Engelman J.A., Lee R.J., Karnezis A., Bearss D.J., Webster M., Siegel P., Muller W.J., Windle J.J., Pestell R.G., and Lisanti M.P. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J. Biol. Chem. 273 (1998) 20448-20455
14. Couet J., Sargiacomo M., and Lisanti M.P. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272 (1997) 30429-30438
15. Engelman J.A., Chu C., Lin A., Jo H., Ikezu T., Okamoto T., Kohtz D.S., and Lisanti M.P. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428 (1998) 205-211
16. Engelman J.A., Wykoff C.C., Yasuhara S., Song K.S., Okamoto T., and Lisanti M.P. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272 (1997) 16374-16381
17. Lee S.W., Reimer C.L., Oh P., Campbell D.B., and Schnitzer J.E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16 (1998) 1391-1397
18. Fiucci G., Ravid D., Reich R., and Liscovitch M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21 (2002) 2365-2375
19. Williams T.M., Cheung M.W., Park D.S., Razani B., Cohen A.W., Muller W.J., Di Vizio D., Chopra N.G., Pestell R.G., and Lisanti M.P. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol. Biol. Cell 14 (2003) 1027-1042
20. Capozza F., Williams T.M., Schubert W., McClain S., Bouzahzah B., Sotgia F., and Lisanti M.P. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol. 162 (2003) 2029-2039
21. Lavie Y., Fiucci G., and Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273 (1998) 32380-32383
22. Yang C.-P.H., Galbiati F., Volonte D., Horwitz S.B., and Lisanti M.P. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett. 439 (1998) 368-372
23. Yang G., Truong L.D., Timme T.L., Ren C., Wheeler T.M., Park S.H., Nasu Y., Bangma C.H., Kattan M.W., Scardino P.T., and Thompson T.C. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4 (1998) 1873-1880
24. Liscovitch M., Burgermeister E., Jain N., Ravid D., Shatz M., and Tencer L. Caveolin and cancer: a complex relationship. Membrane Microdomain Signaling. Lipid Rafts in Biology and Medicine (2005), Humana Press, Totowa, New Jersey 161-190
25. Williams T.M., and Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288 (2005) C494-C506
26. Shatz M., and Liscovitch M. Caveolin-1: a tumor-promoting role in human cancer. Int. J. Radiat. Biol. 84 (2008) 177-189
27. Nasu Y., Timme T.L., Yang G., Bangma C.H., Li L., Ren C., Park S.H., DeLeon M., Wang J., and Thompson T.C. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat. Med. 4 (1998) 1062-1064
28. Timme T.L., Goltsov A., Tahir S., Li L., Wang J., Ren C., Johnston R.N., and Thompson T.C. Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene 19 (2000) 3256-3265
29. Tahir S.A., Yang G., Ebara S., Timme T.L., Satoh T., Li L., Goltsov A., Ittmann M., Morrisett J.D., and Thompson T.C. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res. 61 (2001) 3882-3885
30. Ravid D., Maor S., Werner H., and Liscovitch M. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene 24 (2005) 1338-1347
31. C. Glait, L. Tencer, D. Ravid, R. Sarfstein, M. Liscovitch, H. Werner, Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways, Exp. Cell Res. 312 (2006) (in press).
32. Duxbury M.S., Ito H., Ashley S.W., and Whang E.E. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J. Biol. Chem. 279 (2004) 23176-23182
33. Loza-Coll M.A., Perera S., Shi W., and Filmus J. A transient increase in the activity of Src-family kinases induced by cell detachment delays anoikis of intestinal epithelial cells. Oncogene 24 (2005) 1727-1737
34. Williams T.M., Hassan G.S., Li J., Cohen A.W., Medina F., Frank P.G., Pestell R.G., Di Vizio D., Loda M., and Lisanti M.P. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer. Genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J. Biol. Chem. 280 (2005) 25134-25145
35. Navarro A., Anand-Apte B., and Parat M.O. A role for caveolae in cell migration. FASEB J. 18 (2004) 1801-1811
36. Parat M.O., Anand-Apte B., and Fox P.L. Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol. Biol. Cell 14 (2003) 3156-3168
37. 2+wave initiation move with caveolae to the trailing edge of migrating cells. J. Cell Sci. 115 (2002) 475-484
38. Beardsley A., Fang K., Mertz H., Castranova V., Friend S., and Liu J. Loss of caveolin-1 polarity impedes endothelial cell polarization and directional movement. J. Biol. Chem. 280 (2005) 3541-3547
39. Bulotta S., Cerullo A., Barsacchi R., Palma C.D., Rotiroti D., Clementi E., and Borgese N. Endothelial nitric oxide synthase is segregated from caveolin-1 and localizes to the leading edge of migrating cells. Exp. Cell Res. 312 (2006) 877-889
40. Ikeda S., Ushio-Fukai M., Zuo L., Tojo T., Dikalov S., Patrushev N.A., and Alexander R.W. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 96 (2005) 467-475
41. Lee H., Volonte D., Galbiati F., Iyengar P., Lublin D.M., Bregman D.B., Wilson M.T., Campos-Gonzalez R., Bouzahzah B., Pestell R.G., Scherer P.E., and Lisanti M.P. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol. Endocrinol. 14 (2000) 1750-1775
42. Podar K., Shringarpure R., Tai Y.T., Simoncini M., Sattler M., Ishitsuka K., Richardson P.G., Hideshima T., Chauhan D., and Anderson K.C. Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib. Cancer Res. 64 (2004) 7500-7506
43. Gingras D., Gauthier F., Lamy S., Desrosiers R.R., and Beliveau R. Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains. Biochem. Biophys. Res. Commun. 247 (1998) 888-893
44. Cho K.A., Ryu S.J., Oh Y.S., Park J.H., Lee J.W., Kim H.P., Kim K.T., Jang I.S., and Park S.C. Morphological adjustment of senescent cells by modulating caveolin-1 status. J. Biol. Chem. 279 (2004) 42270-42278
45. Stossel T.P., Condeelis J., Cooley L., Hartwig J.H., Noegel A., Schleicher M., and Shapiro S.S. Filamins as integrators of cell mechanics and signalling. Nat. Rev. Mol. Cell Biol. 2 (2001) 138-145
46. Feng Y., and Walsh C.A. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat. Cell Biol. 6 (2004) 1034-1038
47. Zhang H., Zha X., Tan Y., Hornbeck P.V., Mastrangelo A.J., Alessi D.R., Polakiewicz R.D., and Comb M.J. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem. 277 (2002) 39379-39387
48. Deshmukh A., Coffey V.G., Zhong Z., Chibalin A.V., Hawley J.A., and Zierath J.R. Exercise-induced phosphorylation of the novel Akt substrates AS160 and filamin A in human skeletal muscle. Diabetes 55 (2006) 1776-1782
49. Ramsby M.L., Makowski G.S., and Khairallah E.A. Differential detergent fractionation of isolated hepatocytes: biochemical, immunochemical and two-dimensional gel electrophoresis characterization of cytoskeletal and noncytoskeletal compartments. Electrophoresis 15 (1994) 265-277
50. Beer I., Barnea E., Ziv T., and Admon A. Improving large-scale proteomics by clustering of mass spectrometry data. Proteomics 4 (2004) 950-960
51. Reich R., Royce L.S., and Martin G.R. Eicosapentaenoic acid reduces invasive and metastatic activities of malignant tumor cells. Biochem. Biophys. Res. Commun. 160 (1989) 559-564
52. Monier S., Parton R.G., Vogel F., Behlke J., Henske A., and Kurzchalia T.V. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell 6 (1995) 911-927
53. Obenauer J.C., Cantley L.C., and Yaffe M.B. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31 (2003) 3635-3641
54. Stahlhut M., and van Deurs B. Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol. Biol. Cell 11 (2000) 325-337
55. Cox D., Condeelis J., Wessels D., Soll D., Kern H., and Knecht D.A. Targeted disruption of the ABP-120 gene leads to cells with altered motility. J. Cell Biol. 116 (1992) 943-955
56. Cunningham C.C., Gorlin J.B., Kwiatkowski D.J., Hartwig J.H., Janmey P.A., Byers H.R., and Stossel T.P. Actin-binding protein requirement for cortical stability and efficient locomotion. Science 255 (1992) 325-327
57. Fox J.W., Lamperti E.D., Eksioglu Y.Z., Hong S.E., Feng Y., Graham D.A., Scheffer I.E., Dobyns W.B., Hirsch B.A., Radtke R.A., Berkovic S.F., Huttenlocher P.R., and Walsh C.A. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 21 (1998) 1315-1325
58. Robertson S.P. Filamin A: phenotypic diversity. Curr. Opin. Genet. Dev. 15 (2005) 301-307
59. Vadlamudi R.K., Li F., Adam L., Nguyen D., Ohta Y., Stossel T.P., and Kumar R. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat. Cell Biol. 4 (2002) 681-690
60. Woo M.S., Ohta Y., Rabinovitz I., Stossel T.P., and Blenis J. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Mol. Cell. Biol. 24 (2004) 3025-3035
61. Razani B., Schlegel A., Liu J., and Lisanti M.P. Caveolin-1, a putative tumour suppressor gene. Biochem. Soc. Trans. 29 (2001) 494-499
62. Williams T.M., Medina F., Badano I., Hazan R.B., Hutchinson J., Muller W.J., Chopra N.G., Scherer P.E., Pestell R.G., and Lisanti M.P. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J. Biol. Chem. 279 (2004) 51630-51646
63. Hayashi K., Matsuda S., Machida K., Yamamoto T., Fukuda Y., Nimura Y., Hayakawa T., and Hamaguchi M. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61 (2001) 2361-2364
64. Li T., Sotgia F., Vuolo M.A., Li M., Yang W.C., Pestell R.G., Sparano J.A., and Lisanti M.P. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am. J. Pathol. 168 (2006) 1998-2013
65. Timme T.L., Satoh T., Tahir S.A., Wang H., Teh B.S., Butler E.B., Miles B.J., Amato R.J., Kadmon D., and Thompson T.C. Therapeutic targets for metastatic prostate cancer. Curr. Drug Targets 4 (2003) 251-261
66. Ravid D., Maor S., Werner H., and Liscovitch M. Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Adv. Enzyme Regul. 46 (2006) 163-175
67. M. Shatz, G. Lustig, R. Reich, M. Liscovitch, Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells (submited).
68. Jay D., Garcia E.J., and de la Luz Ibarra M. In situ determination of a PKA phosphorylation site in the C-terminal region of filamin. Mol. Cell. Biochem. 260 (2004) 49-53
69. Chen M., and Stracher A. In situ phosphorylation of platelet actin-binding protein by cAMP-dependent protein kinase stabilizes it against proteolysis by calpain. J. Biol. Chem. 264 (1989) 14282-14289
70. Garcia E., Stracher A., and Jay D. Calcineurin dephosphorylates the C-terminal region of filamin in an important regulatory site: a possible mechanism for filamin mobilization and cell signaling. Arch. Biochem. Biophys. 446 (2006) 140-150
71. Alessi D.R., Caudwell F.B., Andjelkovic M., Hemmings B.A., and Cohen P. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399 (1996) 333-338
72. Obata T., Yaffe M.B., Leparc G.G., Piro E.T., Maegawa H., Kashiwagi A., Kikkawa R., and Cantley L.C. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 275 (2000) 36108-36115
73. Wharton J., Meshulam T., Vallega G., and Pilch P. Dissociation of insulin receptor expression and signaling from caveolin-1 expression. J. Biol. Chem. 280 (2005) 13483-13486
74. Kim J.H., Han J.M., Lee S., Kim Y., Lee T.G., Park J.B., Lee S.D., Suh P.G., and Ryu S.H. Phospholipase D1 in caveolae: regulation by protein kinase C-a and caveolin-1. Biochemistry 38 (1999) 3763-3769
75. Yoeli-Lerner M., Yiu G.K., Rabinovitz I., Erhardt P., Jauliac S., and Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20 (2005) 539-550
76. Irie H.Y., Pearline R.V., Grueneberg D., Hsia M., Ravichandran P., Kothari N., Natesan S., and Brugge J.S. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171 (2005) 1023-1034
77. Barber M.A., and Welch H.C. PI3K and RAC signalling in leukocyte and cancer cell migration. Bull. Cancer 93 (2006) E44-E52
78. Yuan Y., and Shen Z. Interaction with BRCA2 suggests a role for filamin-1 (hsFLNa) in DNA damage response. J. Biol. Chem. 276 (2001) 48318-48324
79. Meng X., Yuan Y., Maestas A., and Shen Z. Recovery from DNA damage-induced G2 arrest requires actin-binding protein filamin-A/actin-binding protein 280. J. Biol. Chem. 279 (2004) 6098-6105
80. Glogauer M., Arora P., Chou D., Janmey P.A., Downey G.P., and McCulloch C.A. The role of actin-binding protein 280 in integrin-dependent mechanoprotection. J. Biol. Chem. 273 (1998) 1689-1698
81. Kainulainen T., Pender A., D'Addario M., Feng Y., Lekic P., and McCulloch C.A. Cell death and mechanoprotection by filamin a in connective tissues after challenge by applied tensile forces. J. Biol. Chem. 277 (2002) 21998-22009
82. Radel C., and Rizzo V. Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H936-H945
83. Sedding D.G., Hermsen J., Seay U., Eickelberg O., Kummer W., Schwencke C., Strasser R.H., Tillmanns H., and Braun-Dullaeus R.C. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ. Res. 96 (2005) 635-642
84. Yu J., Bergaya S., Murata T., Alp I.F., Bauer M.P., Lin M.I., Drab M., Kurzchalia T.V., Stan R.V., and Sessa W.C. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J. Clin. Invest. 116 (2006) 1284-1291